CHARLOTTE NEAL: Open Payments
NPI 1902200017 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 31 payments from 13 companies in 2025. Trend: 2023 $247 · 2024 $503 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 8 | $189 |
| Astellas Pharma US Inc | 7 | $140 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $60 |
| Pharmacosmos Therapeutics Inc. | 2 | $38 |
| Organon LLC | 2 | $22 |
| Dynavax Technologies Corporation | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Hologic Sales and Service, LLC | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| SHIELD THERAPEUTICS INC | 1 | $15 |
Products named: ZURZUVAE, Veozah, MONOFERRIC, NEXPLANON, Heplisav-B, GEMTESA, APTIMA, LILETTA.
Industry payments across IN — which companies pay providers there.
